Suppr超能文献

用塞拉菌素或伊维菌素治疗兔疥螨病:一项回顾性病例研究。

Treatment of rabbit cheyletiellosis with selamectin or ivermectin: a retrospective case study.

作者信息

Mellgren Marianne, Bergvall Kerstin

机构信息

Djurklinik Stigsbo, Stigsbo 213, Stjärnsund, Sweden.

出版信息

Acta Vet Scand. 2008 Jan 2;50(1):1. doi: 10.1186/1751-0147-50-1.

Abstract

BACKGROUND

A retrospective study of rabbits treated against cheyletiellosis was performed to evaluate the efficacy and safety of selamectin or ivermectin in clinical practice.

METHODS

Medical records from 53 rabbits with microscopically confirmed Cheyletiella infestation were collected from two small animal clinics. The rabbits were divided into three groups, based on treatment protocols. Group 1 included 11 rabbits treated with ivermectin injections at 200-476 microg kg-1 subcutaneously 2-3 times, with a mean interval of 11 days. In Group 2, 27 rabbits were treated with a combination of subcutaneous ivermectin injections (range 618-2185 microgkg-1) and oral ivermectin (range 616-2732 microgkg-1) administered by the owners, 3-6 times at 10 days interval. The last group (Group 3) included 15 rabbits treated with selamectin spot-on applications of 6.2-20,0 mgkg-1, 1-3 times with an interval of 2-4 weeks. Follow-up time was 4 months-4.5 years.

RESULTS

Rabbits in remission were 9/11 (81,8%), 14/27 (51,9%) and 12/15 (80,8%) in groups 1, 2 and 3, respectively.

CONCLUSION

All treatment protocols seemed to be sufficiently effective and safe for practice use. Though very high doses were used in Group 2 (ivermectin injections followed by oral administration), the protocol seemed less efficacious compared to ivermectin injections (Group 1) and selamectin spot on (Group 3), respectively, although not statistically significant. Controlled prospective studies including larger groups are needed to further evaluate efficacy of the treatment protocols.

摘要

背景

开展了一项针对兔疥螨病治疗的回顾性研究,以评估塞拉菌素或伊维菌素在临床实践中的疗效和安全性。

方法

从两家小动物诊所收集了53只经显微镜确诊感染兔疥螨的兔子的病历。根据治疗方案将兔子分为三组。第1组包括11只兔子,皮下注射伊维菌素,剂量为200 - 476微克/千克,注射2 - 3次,平均间隔11天。第2组有27只兔子,由主人皮下注射伊维菌素(剂量范围为618 - 2185微克/千克)并口服伊维菌素(剂量范围为616 - 2732微克/千克),间隔10天给药3 - 6次。最后一组(第3组)包括15只兔子,采用6.2 - 20.0毫克/千克的塞拉菌素滴剂进行体表滴注,给药1 - 3次,间隔2 - 4周。随访时间为4个月至4.5年。

结果

第1组、第2组和第3组病情缓解的兔子分别为9/11(81.8%)、14/27(51.9%)和12/15(80.8%)。

结论

所有治疗方案在实际应用中似乎都足够有效且安全。尽管第2组使用了非常高的剂量(先皮下注射伊维菌素然后口服),但与伊维菌素注射组(第1组)和塞拉菌素滴剂组(第3组)相比,该方案的疗效似乎较低,尽管差异无统计学意义。需要开展纳入更大样本量的对照前瞻性研究,以进一步评估这些治疗方案的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d199/2235873/5d69ae4d6bff/1751-0147-50-1-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验